PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
NCT06755775 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2025-01-01
Summary
This study aims to investigate the predictive value of PET imaging targeting granzyme B on the outcome of patients with diffuse large B lymphoma receiving immunotherapy.
Conditions
- Diffuse Large B-Cell Lymphoma
Sponsors & Collaborators
-
Ruijin Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-07-23
- Primary Completion
- 2029-07-23
- Completion
- 2029-07-23
Countries
- China
Study Locations
More Related Trials
-
Granzyme B-targeted PET Imaging Monitoring Tumor Responses to Immunotherapy
NCT06916442 ·Status: NOT_YET_RECRUITING
-
18F-FDG PET Scan and MRI Diffusion.Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma
NCT03121456 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors
NCT04169321 ·Status: COMPLETED ·Phase: PHASE1
-
Interim FDG PET/CT in Diffuse Large B Cell Lymphoma (DLBCL) Patients
NCT01357733 ·Status: UNKNOWN ·Phase: NA
-
Combining Intratumoral Metabolic Heterogeneity and Dissemination Feature (Dmax) on 18F-FDG PET/CT Improves Prognosis Prediction in DLBCL
NCT05113576 ·Status: COMPLETED
-
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma
NCT02931201 ·Status: UNKNOWN ·Phase: NA
-
FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
NCT01410630 ·Status: COMPLETED
-
Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma
NCT06795113 ·Status: RECRUITING
-
68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.
NCT06608160 ·Status: RECRUITING
-
PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
NCT05662540 ·Status: RECRUITING ·Phase: NA
-
Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PET
NCT07070648 ·Status: RECRUITING
-
CD70-targeted immunoPET Imaging of Malignant Cancers
NCT06852638 ·Status: RECRUITING ·Phase: PHASE2
-
68Ga-grazytracer PET/CT of Tumor Responses to Immunotherapy
NCT05000372 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT
NCT00256490 ·Status: COMPLETED ·Phase: NA
-
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma
NCT03051555 ·Status: UNKNOWN ·Phase: NA
-
Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV
NCT00286832 ·Status: COMPLETED
-
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary Malignancy
NCT06597539 ·Status: RECRUITING
-
Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)
NCT01004718 ·Status: COMPLETED ·Phase: NA
-
PET / CT Imaging and Safety in Patients With Lymphoma Treated With CD19 Car-t Cells
NCT05176275 ·Status: UNKNOWN ·Phase: NA
-
Detection and Characterization of Residual Masses in Lymphomas
NCT02300402 ·Status: COMPLETED
-
The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study
NCT06747299 ·Status: NOT_YET_RECRUITING
-
Wholebody MRI In Lung Cancer StagiNg
NCT02716051 ·Status: COMPLETED ·Phase: NA
-
FDG-PET/CT Imaging as Early Predictor of DP
NCT02476734 ·Status: COMPLETED
-
Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)
NCT00754117 ·Status: COMPLETED
-
FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma
NCT00530179 ·Status: COMPLETED ·Phase: NA